FRNRX
Price
$30.98
Change
+$0.26 (+0.85%)
Updated
Jun 13 closing price
Net Assets
317.35M
RYBCX
Price
$57.57
Change
-$0.43 (-0.74%)
Updated
Jun 13 closing price
Net Assets
23.66M
Interact to see
Advertisement

FRNRX vs RYBCX

Header iconFRNRX vs RYBCX Comparison
Open Charts FRNRX vs RYBCXBanner chart's image
Franklin Natural Resources A
Price$30.98
Change+$0.26 (+0.85%)
VolumeN/A
Net Assets317.35M
Rydex Basic Materials C
Price$57.57
Change-$0.43 (-0.74%)
VolumeN/A
Net Assets23.66M
FRNRX vs RYBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRNRX vs. RYBCX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRNRX is a Buy and RYBCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FRNRX has more cash in the bank: 317M vs. RYBCX (23.7M). FRNRX pays higher dividends than RYBCX: FRNRX (2.40) vs RYBCX (0.06). FRNRX was incepted earlier than RYBCX: FRNRX (30 years) vs RYBCX (24 years). RYBCX (2.43) is less costly to investors than FRNRX (1.02). RYBCX is a more actively managed with annual turnover of: 49.00 vs. FRNRX (11.86). FRNRX has a lower initial minimum investment than RYBCX: FRNRX (1000) vs RYBCX (2500). FRNRX annual gain was more profitable for investors over the last year : 5.56 vs. RYBCX (-8.81). FRNRX return over 5 years is better than : 124.49 vs. RYBCX (42.39).
FRNRXRYBCXFRNRX / RYBCX
Total Expense Ratio1.012.4042%
Annual Report Gross Expense Ratio1.022.4342%
Fund Existence30 years24 years-
Gain YTD8.7879.28295%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets317M23.7M1,338%
Annual Yield % from dividends2.400.063,991%
Returns for 1 year5.56-8.81-63%
Returns for 3 years16.46-0.21-7,830%
Returns for 5 years124.4942.39294%
Returns for 10 years13.8043.4732%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMORX38.11N/A
N/A
Patient Opportunity R
HFQDX6.90-0.05
-0.72%
Janus Henderson Global Equity Income D
VVSGX16.11-0.28
-1.71%
VALIC Company I Small Cap Growth
TLGYX60.66-1.09
-1.77%
Touchstone Large Company Growth Y
RYMDX122.51-2.92
-2.33%
Rydex Mid-Cap 1.5x Strategy H